Cargando…

Identification of potential biomarkers for idiopathic pulmonary fibrosis and validation of TDO2 as a potential therapeutic target

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease with a high mortality rate. On this basis, exploring potential therapeutic targets to meet the unmet needs of IPF patients is important. AIM: To explore novel hub genes for IPF therapy. METHODS: Here, we used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ru, Yang, Yan-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308271/ https://www.ncbi.nlm.nih.gov/pubmed/37397828 http://dx.doi.org/10.4330/wjc.v15.i6.293

Ejemplares similares

Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis
por: Qian, Weibin, et al.
Publicado: (2021)

Pharmacological validation of TDO as a target for Parkinson’s disease
por: Perez‐Pardo, Paula, et al.
Publicado: (2021)

Potential role of long noncoding RNA RP5-881L22.5 as a novel biomarker and therapeutic target of colorectal cancer
por: Zong, Hua, et al.
Publicado: (2022)

Therapeutic potential of targeting kinase inhibition in patients with idiopathic pulmonary fibrosis
por: Kim, Suji, et al.
Publicado: (2020)

Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma
por: Wang, Xi, et al.
Publicado: (2022)

In vivo hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells: Therapeutic effect on liver fibrosis/cirrhosis
por: Zhang, Guo-Zun, et al.
Publicado: (2017)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis()
por: Sehgal, Manas, et al.
Publicado: (2022)

γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus
por: Saengboonmee, Charupong, et al.
Publicado: (2023)

Bioinformatics prediction of potential mechanisms and biomarkers underlying dilated cardiomyopathy
por: Liu, Zhou, et al.
Publicado: (2022)

Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer
por: Zhu, Xiao-Liang, et al.
Publicado: (2019)

Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis
por: Machahua, Carlos, et al.
Publicado: (2018)

Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis
por: Wang, Qing, et al.
Publicado: (2023)

Molecular profiling reveals potential targets in cholangiocarcinoma
por: Liu, Dan, et al.
Publicado: (2023)

Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis
por: Inomata, Minoru, et al.
Publicado: (2015)

Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers
por: Wang, Xueyin, et al.
Publicado: (2021)

Bioinformatic identification and analysis of immune-related chromatin regulatory genes as potential biomarkers in idiopathic pulmonary fibrosis
por: Li, Kaixin, et al.
Publicado: (2022)

Therapeutic potential of menstrual blood stem cells in treating acute liver failure
por: Cen, Pan-Pan, et al.
Publicado: (2019)

Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis–related genes and potential therapeutic drugs
por: Zhang, Zhenzhen, et al.
Publicado: (2023)

Increased KIF21B expression is a potential prognostic biomarker in hepatocellular carcinoma
por: Zhao, Hui-Qi, et al.
Publicado: (2020)

VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors
por: Wang, Mu-Qi, et al.
Publicado: (2022)

CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential
por: Liu, Shanshan, et al.
Publicado: (2023)

Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel
por: Hiraishi, Keizo, et al.
Publicado: (2018)

Investigating the specificity of endothelin-traps as a potential therapeutic tool for endothelin-1 related disorders
por: Jain, Arjun, et al.
Publicado: (2022)

RNA-Seq profiling of circular RNAs in human colorectal cancer 5-fluorouracil resistance and potential biomarkers
por: Cheng, Pei-Qiu, et al.
Publicado: (2022)

Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett’s esophagus
por: Lv, Jing, et al.
Publicado: (2019)

Identification of targetable kinases in idiopathic pulmonary fibrosis
por: Higo, Hisao, et al.
Publicado: (2022)

The identification of metabolism-related subtypes and potential treatments for idiopathic pulmonary fibrosis
por: Yang, Changqing, et al.
Publicado: (2023)

Identification of candidate biomarkers correlated with pathogenesis of postoperative peritoneal adhesion by using microarray analysis
por: Bian, Yao-Yao, et al.
Publicado: (2020)

Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications
por: Ye, Zixiang, et al.
Publicado: (2019)

Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth
por: Wu, Meng-Na, et al.
Publicado: (2021)

The Therapeutic Potential of Conditioned Medium from Human Breast Milk Stem Cells in Treating Spinal Cord Injury
por: Borhani-Haghighi, Maryam, et al.
Publicado: (2020)

Identifying potential biomarkers of idiopathic pulmonary fibrosis through machine learning analysis
por: Wu, Zenan, et al.
Publicado: (2023)

Dihydroergotamine ameliorates liver fibrosis by targeting transforming growth factor β type II receptor
por: Zheng, Ke-Xin, et al.
Publicado: (2023)

Identification and optimisation of next generation inhibitors of IDO1 and TDO
por: Wise, Alan, et al.
Publicado: (2015)

The Role of Extracellular Vesicles in Idiopathic Pulmonary Fibrosis Progression: An Approach on Their Therapeutics Potential
por: Ramírez-Hernández, Alma Aurora, et al.
Publicado: (2022)

Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics
por: Yan, Feng, et al.
Publicado: (2017)

Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results
por: Mallis, Panagiotis, et al.
Publicado: (2022)

Identification and Validation of Aging-Related Genes in Idiopathic Pulmonary Fibrosis
por: He, Jie, et al.
Publicado: (2022)

Pancancer Analysis of Revealed TDO2 as a Biomarker of Prognosis and Immunotherapy
por: Cui, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1725de2oc62hvgnlnb2iiufdrj